The U.S. House of Representatives has approved without modification a Senate bill (S. 2141) that would establish a process for the Food and Drug Administration’s (FDA’s) approval of the active ingredients in over-the-counter sunscreen products. It now awaits the president’s signature. “The Sunscreen Innovation Act” would limit FDA to 300 days from the date of application to issue a proposed order reflecting its determination that an ingredient is generally recognized as safe and effective (GRASE ) for use in nonprescription sunscreens. It would also require the agency to issue draft guidance within one year of enactment to explain what information and data will be needed for applicants to demonstrate that a particular ingredient meets the “safety and efficacy standard for determining whether a nonprescription sunscreen active ingredient or combination of nonprescription sunscreen active ingredients is GRASE and is not misbranded.” The legislation would further require the Government Accountability Office to issue a report within three years on FDA’s progress in completing the required reviews.